Trial Profile
Pulmonary Arterial Capacitance Predicts 1-Year Survival but Not Change in 6-Minute Walk Distance in Pulmonary Arterial Hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Mar 2016
Price :
$35
*
At a glance
- Drugs Beraprost (Primary) ; Treprostinil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 04 Mar 2016 New trial record